Pharmacological interactions of anti-inflammatory-analgesics in odontology

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 14, Issue 2, 2009, Pages

  Gómez Moreno, Gerardo ^a   Guardia, Javier ^a   Cutando, Antonio ^a   Guirado, José Luis Calvo ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Alcohol; ARA II; Beta blockers; Diuretics; IACE; NSAI; Odontology; Opiates; Paracetamol; Pharmacological interaction; SIRS

Indexed keywords

ALCOHOL; ANALGESIC AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPROPAMIDE; DEXTROPROPOXYPHENE; DIFLUNISAL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENCLOFENAC; GLIBENCLAMIDE; HERBACEOUS AGENT; LITHIUM; LOOP DIURETIC AGENT; METFORMIN; METHOTREXATE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; TRAMADOL; UNINDEXED DRUG; WARFARIN;

ANALGESIA; ANXIETY; CLINICAL TRIAL; COMA; CONVULSION; DENTAL PRACTICE; DIABETES MELLITUS; DIARRHEA; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; KIDNEY BLOOD FLOW; MOUTH CAVITY; MOUTH INFLAMMATION; NAUSEA; NONHUMAN; ODONTOLOGY; PAIN; POLYDIPSIA; POLYURIA; PRESCRIPTION; REVIEW; SEDATION; SEROTONIN SYNDROME; SIDE EFFECT; TREMOR; VOMITING;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DENTISTRY; HUMANS; NARCOTICS;

EID: 59949104066     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Haas DA. Adverse drug interactions in dental practice: interactions associated with analgesics, Part III in a series. J Am Dent Assoc. 1999;130:397-407.
2. Stockley IH. Stockley's Drug Interactions. 6th ed. London: Pharmaceutical Press; 2002.
3. Gómez Moreno G, Cutando A, Arana C. Visión Odontológica de las Interacciones Farmacológicas. Granada: Grupo Editorial Univer-sitario; 2006.
4. Meechan JG. Polypharmacy and dentistry: 2. Interactions with analgesics and antimicrobials. Dent Update. 2002;29:382-8.
5. Hersh EV, Pinto A, Moore PA. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther. 2007;29:2477-97.
6. Hersh EV, Moore PA. Drug interactions in dentistry: the importance of knowing your CYPs. J Am Dent Assoc. 2004;135:298-311.
7. Sims PJ, Sims KM. Drug interactions important for periodontal therapy. Periodontol 2000. 2007;44:15-28.
8. Moore PA, Nahouraii HS, Zovko JG, Wisniewski SR. Dental therapeutic practice patterns in the U.S. II. Analgesics, corticosteroids, and antibiotics. Gen Dent. 2006;54:201-7.
9. Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology. 1995;45:219-23.
10. Hersh EV, Moore PA. Adverse drug interactions in dentistry. Periodontol 2000. 2008;46:109-42.
11. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA. 1998;279:657-62.
12. McClain CJ, Kromhout JP, Peterson FJ, Holtzman JL. Po-tentiation of acetaminophen hepatotoxicity by alcohol. JAMA. 1980;244:251-3.
13. Moore PA, Gage TW, Hersh EV, Yagiela JA, Haas DA. Adverse drug interactions in dental practice. Professional and educational implications. J Am Dent Assoc. 1999;130:47-54.
14. Gómez-Moreno G, Guardia J, Cutando A. Interaction of paracetamol in chronic alcoholic patients. Importance for odontologists. Med Oral Patol Oral Cir Bucal. 2008;13:E235-8.
15. Poveda Roda R, Bagán JV, Jiménez Soriano Y, Gallud Romero L. Use of nonsteroidal antiinflammatory drugs in dental practice. A review. Med Oral Patol Oral Cir Bucal. 2007;12:E10-8.
16. Fitzgerald GA. Coxibs and cardiovascular disease. N Engl J Med. 2004;351:1709-11.
17. Jiménez Y, Poveda R, Gavaldá C, Margaix M, Sarrión G. An update on the management of anticoagulated patients programmed for dental extractions and surgery. Med Oral Patol Oral Cir Bucal. 2008;13:E176-9.
18. Thyss A, Milano G, Kubar J, Namer M, Schneider M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet. 1986;1:256-8.
19. Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonste-roidal anti-inflammatory drugs. J Clin Psychiatry. 2003;64:1328-34.
20. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 1993;153:477-84.
21. Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med. 1987;107:628-35.
22. Burnier M. Angiotensin II type 1 receptor blockers. Circulation. 2001;103:904-12.
23. Goa KL, Wagstaff AJ. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs. 1996;51:820-45.
24. Tamargo J, Caballero R, Gómez R, Núñez L, Vaquero M, Delpón E. Características farmacológicas de los ARA-II. ¿ Son todos iguales?. Rev Esp Cardiol. 2006;6:10-24.
25. Herchuelz A, Derenne F, Deger F, Juvent M, Van Ganse E, Sta-roukine M, et al. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance. J Pharmacol Exp Ther. 1989;248:1175-81.
26. Driesen A, Simoens S, Laekeman G. Management of drug interactions with beta-blockers: continuing education has a short-term impact. Pharmacy Practice 2006;4:143-150.
27. Houston MC, Weir M, Gray J, Ginsberg D, Szeto C, Kaihlenen PM, et al. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med. 1995;155:1049-54.
28. Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?. Am J Med. 2006;119:113-6.
29. Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003;163:59-64.
30. De Jong JC, Van den Berg PB, Tobi H, De Jong-van den Berg LT. Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects. Br J Clin Pharmacol. 2003;55:591-5.